Showing results (111-120 of 370) with videos related to
Sort By:
Pageof 37
Diabetes Research and Clinical Practice|January 1, 1987
The effect of non-esterified fatty acids on vascular ADP-degrading enzyme activityM A Barradas, D P Mikhailidis, P DandonaNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1989
Dietary fish oil supplements preserve renal function in renal transplant recipients with chronic vascular rejectionP Sweny, D C Wheeler, S F Lui, et al.Platelets|November 4, 2010
N-formyl-methionine-leucine-phenylalanine (fMLP), a Bacterial Chemotactic Peptide, Stimulates Platelet Shape Change in Human Whole BloodM L Nystrom, M A Barradas, D P MikhailidisCurrent Pharmaceutical Design|June 23, 2007
Platelets and vascular risk: an option for treatmentI A Jagroop, A I Kakafika, D P MikhailidisPlatelets|June 28, 2006
Platelets and lipoprotein (a): a brief overview of their role in the pathogenesis of atherothrombosisH J Milionis, D P Mikhailidis, A F WinderJournal of Clinical Pathology|August 29, 2000
Lipoprotein (a) and strokeH J Milionis, A F Winder, D P MikhailidisThe Journal of the Royal Society for the Promotion of Health|July 27, 2001
Time to look beyond just lowering the serum concentration of low density lipoprotein--high density lipoprotein levels are also importantD R Nair, A S Wierzbicki, D P MikhailidisCurrent Medical Research and Opinion|May 2, 2001
Sildenafil: a urologist's viewM A Khan, D P Mikhailidis, R J MorganPlatelets|June 19, 2004
Dextran 40 reduces in vitro platelet aggregation in peripheral arterial diseaseP Robless, D Okonko, D P Mikhailidis, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 31, 1994
Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human plateletsM A Barradas, I A Jagroop, D P MikhailidisPageof 37